Impact of G12 Mutations on the Structure of K-Ras Probed by Ultraviolet Photodissociation Mass Spectrometry.
Single-residue mutations at Gly12 (G12X) in the GTP-ase protein K-Ras can lead to activation of different downstream signaling pathways, depending on the identity of the mutation, through a poorly defined mechanism. Herein, native mass spectrometry combined with top-down ultraviolet photodissociation (UVPD) was employed to investigate the structural changes occurring from G12X mutations of K-Ras. Complexes between K-Ras or the G12X mutants and guanosine 5'-diphosphate (GDP) or GDPnP (a stable GTP analogue) were transferred to the gas phase by nano-electrospray ionization and characterized using UVPD. Variations in the efficiencies of backbone cleavages were observed upon substitution of GDPnP for GDP as well as for the G12X mutants relative to wild-type K-Ras. An increase in the fragmentation efficiency in the segment containing the first 50 residues was observed for the K-Ras/GDPnP complexes relative to the K-Ras/GDP complexes, whereas a decrease in fragmentation efficiency occurred in the segment containing the last 100 residues. Within these general regions, the specific residues at which changes in fragmentation efficiency occurred correspond to the phosphate and guanine binding regions, respectively, and are indicative of a change in the binding motif upon replacement of the ligand (GDP versus GDPnP). Notably, unique changes in UVPD were observed for each G12X mutant with the cysteine and serine mutations exhibiting similar UVPD changes whereas the valine mutation was significantly different. These findings suggest a mechanism that links the identity of the G12X substitution to different downstream effects through long-range conformational or dynamic effects as detected by variations in UVPD fragmentation.
Department of Chemistry, ‡Graduate Program in Biochemistry, and §Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas , Austin, Texas 78712, United States.
Michael B
MB
Cammarata
Department of Chemistry, ‡Graduate Program in Biochemistry, and §Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas , Austin, Texas 78712, United States.
Christopher L
CL
Schardon
Department of Chemistry, ‡Graduate Program in Biochemistry, and §Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas , Austin, Texas 78712, United States.
M Rachel
MR
Mehaffey
Department of Chemistry, ‡Graduate Program in Biochemistry, and §Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas , Austin, Texas 78712, United States.
Jake
J
Rosenberg
Department of Chemistry, ‡Graduate Program in Biochemistry, and §Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas , Austin, Texas 78712, United States.
Jonathan
J
Singleton
Department of Chemistry, ‡Graduate Program in Biochemistry, and §Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas , Austin, Texas 78712, United States.
Walter
W
Fast
Department of Chemistry, ‡Graduate Program in Biochemistry, and §Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas , Austin, Texas 78712, United States.
Jennifer S
JS
Brodbelt